Virtual Medicinal Product (VMP)
-
Alteplase 20mg powder and solvent for solution for injection vials
Name Details
Current Name
Alteplase 20mg powder and solvent for solution for injection vials
|
Start Date
10-06-2004
|
End Date
|
Previous Name
Alteplase 20mg intravenous infusion vials and diluent
|
Start Date
04-09-2003
|
End Date
09-06-2004
|
|
Abbreviated Name
Alteplase 20mg inj vials
|
Start Date
01-05-2009
|
|
Alteplase 20mg pdr & solv for soln for inj vials |
Previous Start Date
06-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder and solvent for solution for injection
- Ontology Form/Route
- solutioninfusion.intravenous, solutioninjection.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
B01AD02
BNF |
Current BNF
02100200
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02100200
|
Start Date
11-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
35899111000001106 |
17-10-2018 |
|
319840006 |
04-09-2003 |
16-10-2018 |
VMP Ingredients
VMP ingredients table
Alteplase |
Based on Ingredient Substance |
|
20 mg |
|
Name
Alteplase
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20
Strength and UOM (Dmr)
Parent Products
-
VTM
Alteplase
-
VMP
(Current) Alteplase 20mg powder and solvent fo...
Virtual Medicinal Product Pack (VMPP) Information